Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapy. (Q51467614)
Jump to navigation
Jump to search
scientific article published on 21 December 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapy. |
scientific article published on 21 December 2011 |
Statements
Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapy. (English)
1 reference
1 reference
Paul M Ridker
1 reference
Robert J Glynn
1 reference
Jonatan D Lindh
1 reference
Benjamin D Horne
1 reference
Petra A Lenzini
1 reference
Andrea L Jorgensen
1 reference
Stephen E Kimmel
1 reference
Niclas Eriksson
1 reference
Jeffrey L Anderson
1 reference
Nita A Limdi
1 reference
Robert C Pendleton
1 reference
Gwendolyn A McMillin
1 reference
James K Burmester
1 reference
Daniel Kurnik
1 reference
C Michael Stein
1 reference
Michael D Caldwell
1 reference
Charles S Eby
1 reference
Anders Rane
1 reference
Jae-Gook Shin
1 reference
Ho-Sook Kim
1 reference
Pantep Angchaisuksiri
1 reference
Kathryn E Kronquist
1 reference
John F Carlquist
1 reference
Gloria R Grice
1 reference
Robert L Barrack
1 reference
Juan Li
1 reference
Brian F Gage
1 reference
21 December 2011
1 reference
107
1 reference
2
1 reference
232-240
1 reference
Identifiers
1 reference